WO2020019033A1 - Récipient pour administration d'inhibiteur d'amylase - Google Patents

Récipient pour administration d'inhibiteur d'amylase Download PDF

Info

Publication number
WO2020019033A1
WO2020019033A1 PCT/AU2019/050781 AU2019050781W WO2020019033A1 WO 2020019033 A1 WO2020019033 A1 WO 2020019033A1 AU 2019050781 W AU2019050781 W AU 2019050781W WO 2020019033 A1 WO2020019033 A1 WO 2020019033A1
Authority
WO
WIPO (PCT)
Prior art keywords
container
inhibitor
amylase
deliver
delivery
Prior art date
Application number
PCT/AU2019/050781
Other languages
English (en)
Inventor
Raymond Denis PALMER
Original Assignee
Palmer Raymond Denis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2018902684A external-priority patent/AU2018902684A0/en
Application filed by Palmer Raymond Denis filed Critical Palmer Raymond Denis
Publication of WO2020019033A1 publication Critical patent/WO2020019033A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J7/00—Devices for administering medicines orally, e.g. spoons; Pill counting devices; Arrangements for time indication or reminder for taking medicine
    • A61J7/0076—Medicament distribution means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/1412—Containers with closing means, e.g. caps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/1468—Containers characterised by specific material properties
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D47/00—Closures with filling and discharging, or with discharging, devices
    • B65D47/04—Closures with discharging devices other than pumps
    • B65D47/06—Closures with discharging devices other than pumps with pouring spouts or tubes; with discharge nozzles or passages
    • B65D47/08—Closures with discharging devices other than pumps with pouring spouts or tubes; with discharge nozzles or passages having articulated or hinged closures
    • B65D47/0804—Closures with discharging devices other than pumps with pouring spouts or tubes; with discharge nozzles or passages having articulated or hinged closures integrally formed with the base element provided with the spout or discharge passage
    • B65D47/0833—Hinges without elastic bias
    • B65D47/0838—Hinges without elastic bias located at an edge of the base element
    • B65D47/0842—Hinges without elastic bias located at an edge of the base element consisting of a strap of flexible material
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D47/00—Closures with filling and discharging, or with discharging, devices
    • B65D47/04—Closures with discharging devices other than pumps
    • B65D47/06—Closures with discharging devices other than pumps with pouring spouts or tubes; with discharge nozzles or passages
    • B65D47/18—Closures with discharging devices other than pumps with pouring spouts or tubes; with discharge nozzles or passages for discharging drops; Droppers
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D47/00—Closures with filling and discharging, or with discharging, devices
    • B65D47/04—Closures with discharging devices other than pumps
    • B65D47/06—Closures with discharging devices other than pumps with pouring spouts or tubes; with discharge nozzles or passages
    • B65D47/18—Closures with discharging devices other than pumps with pouring spouts or tubes; with discharge nozzles or passages for discharging drops; Droppers
    • B65D47/185—Closures with discharging devices other than pumps with pouring spouts or tubes; with discharge nozzles or passages for discharging drops; Droppers with sprinkling devices
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D83/00—Containers or packages with special means for dispensing contents
    • B65D83/06—Containers or packages with special means for dispensing contents for dispensing powdered or granular material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
    • A61J1/06—Ampoules or carpules
    • A61J1/065—Rigid ampoules, e.g. glass ampoules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
    • A61J1/06—Ampoules or carpules
    • A61J1/067—Flexible ampoules, the contents of which are expelled by squeezing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/1412—Containers with closing means, e.g. caps
    • A61J1/1418—Threaded type
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D1/00—Containers having bodies formed in one piece, e.g. by casting metallic material, by moulding plastics, by blowing vitreous material, by throwing ceramic material, by moulding pulped fibrous material, by deep-drawing operations performed on sheet material
    • B65D1/32—Containers adapted to be temporarily deformed by external pressure to expel contents
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D83/00—Containers or packages with special means for dispensing contents
    • B65D83/04—Containers or packages with special means for dispensing contents for dispensing annular, disc-shaped, or spherical or like small articles, e.g. tablets or pills
    • B65D83/0409—Containers or packages with special means for dispensing contents for dispensing annular, disc-shaped, or spherical or like small articles, e.g. tablets or pills the dispensing means being adapted for delivering one article, or a single dose, upon each actuation
    • B65D83/0427—Containers or packages with special means for dispensing contents for dispensing annular, disc-shaped, or spherical or like small articles, e.g. tablets or pills the dispensing means being adapted for delivering one article, or a single dose, upon each actuation the articles being dispensed by inverting the container each time, by which action movable parts may be displaced by their own weight

Definitions

  • the present disclosure relates to a container within which at least one amylase inhibitor is stored, this container has a lid or cap that includes one or more apertures from which the inhibitor can exit the container.
  • the inhibitor is in either a divided form (crystals or particulate matter for example) or in a liquid, or semi-liquid form.
  • Amylase inhibitors have been put forward as one way to reduce the absorption of dietary carbohydrates and/or control blood glucose levels.
  • the amylase inhibitors inhibit the action of the enzyme amylase which is one of the enzymes that breaks down starches and other complex carbohydrates, so the body can process them.
  • amylase is one of the enzymes that breaks down starches and other complex carbohydrates, so the body can process them.
  • these need to be taken as capsules prior to the meal.
  • the present disclosure provides a container including an amylase inhibitor intended to ameliorate one or more of the deficiencies in the prior art, or at least provides the customer with a useful choice.
  • a container including an inhibitor containing at least one amylase inhibitor, such that the container is configured to allow the controlled delivery of the inhibitor, where the container includes a container lid or cap with one or more delivery apertures.
  • the inhibitor is in the form of a particulate material.
  • the lid or cap includes a plurality of delivery apertures.
  • the inhibitor includes more than one amylase inhibitor.
  • the particle size range of each different amylase inhibitor is unique.
  • some of the delivery apertures are dimensioned and configured to pass amylase inhibitors with a specific particle size range.
  • each different amylase inhibitor independently falls between a powder and 4mm
  • the inhibitor is in the form of a liquid, semi-liquid or gel.
  • the side walls of the container are flexible.
  • the container lid or cap includes a cap nozzle with a single delivery aperture.
  • the container further includes a dosage device that that is configured to deliver a predetermined quantity of the inhibitor.
  • the container includes a dosage device that that is configured to deliver a predetermined quantity of one or more amylase inhibitor.
  • the container includes a dosage device that that is configured to deliver a predetermined ratio of amylase inhibitors.
  • a dosage device configured to deliver a predetermined ratio of amylase inhibitors and/or deliver a predetermined quantity of one or more amylase inhibitor and/or deliver a predetermined quantity of the inhibitor
  • Figure 1 is a side view of the first aspect of the container
  • Figure 2 is a top view of a first aspect of the container
  • Figure 3 is a cross sectional view along the line A-A in the direction of arrows;
  • Figure 4 is a pictorial view of the container in use delivering the inhibitor to a target
  • Figure 5 is a side view of the second aspect of the container
  • Figure 6 is a top view of the second aspect of the container
  • Figure 7 is a cross sectional view along the line B-B in the direction of the arrows.
  • Figure 8 is a pictorial view of the container in use delivering the inhibitor to a target.
  • FIG. 1 a first aspect of a container 1 including a container lid or cap 2 and a container body 4 is shown.
  • the container body 4 includes a body base 6 and body wall 8.
  • the body base 6 is the base of the container 1 and the body wall 8 is a wall of the container 1.
  • the body wall 8 is also the outer wall of the container 1, this will not always be the case.
  • the body wall 8 includes a first end 10 which is coterminous with a peripheral edge, the base edge 12, of the body base 6.
  • the container wall 8 is a continuous wall around, or on top of, the body base 6.
  • the combination of the body wall 8 and body base 6 form a vessel adapted to contain particulate solids and/or fluids.
  • 'fluid' includes non-Newtonian and Newtonian fluids, for example liquids, gels, and semi-liquids.
  • Particulate solids are intended to include crystalline and non-crystalline solids in divided form.
  • the particulate solids can vary in size and shape, for example it is intended to include at least particles with sizes similar to coffee crystals, sugar, corn flour, salt, flour, dried herbs, rice, or anything in between.
  • the container lid or cap 2 is shown attached to the body end 13 of the container body 4, in this aspect the body end 13 is coterminous with the second end 14 of the body wall 8.
  • the first end 10 and the second end 14 are the longitudinally opposite ends of the body wall 8.
  • the body wall 8 is a cylinder and the body base 6 is a circular plate upon which the container 1 sits.
  • the container lid or cap 2 in this first aspect, includes a delivery end 20, lid wall 22 and a plurality of delivery apertures 24.
  • the delivery apertures 24 are apertures in the container lid or cap 2 that pass through the delivery end 20.
  • the lid wall 22 includes a primary end 26 that is coterminous with the peripheral edge, the lid edge 27, of the delivery end 20, such that the lid wall 22 forms a wall extending away from the delivery end 20.
  • the delivery end 20 in this first aspect is a circular plate.
  • the lid wall 22 and body end 13 of the container body 4 include complementary features that attach (releasably or permanently) the container lid or cap 2 to the container body 4.
  • the complementary features are any known for attaching lids to containers, for example matching threaded sections, bayonet connection, etc.
  • FIG 3 is a cross sectional view of the container 1 along the line A- A viewed in the direction of the arrows, the container body 4 is shown acting as a receptacle for a particulate form of an inhibitor 30.
  • the inhibitor 30 in this aspect is one or more amylase inhibitor, where an amylase inhibitor is a compound or material that acts to inhibit (reduce or prevent the activity) of the enzyme amylase (ct-amylase in humans).
  • the inhibitor 30 may be a single amylase inhibitor, or a mixture or combination of more than one amylase inhibitor.
  • amylase inhibitor is wide, for example, some researchers recognise 6 classes of amylase inhibitors (specifically alpha-amylase inhibitors) based on their tertiary structures: lectin-like, knottin-like, cereal-type, Kunitz-like, y-purothionin-like and thaumatin-like inhibitors. Other researchers (see Table 1, in ct-Amylase Inhibitors: A Review of Raw Material and Isolated Compounds from Plant Source, J Pharm Pharmaceut. Sci. 15(1) 141 - 183, 2012) simply list a variety of materials found to have the required activity.
  • each delivery aperture 24 is shown as a circle dimensioned to allow the inhibitor 30 ( Figure 3) to pass through the container lid or cap 2.
  • the delivery apertures 24 are dimensioned to allow the inhibitor 30 to pass through in a controlled manner.
  • the inhibitor 30 includes three different amylase inhibitors 31, 32, 33.
  • Each amylase inhibitor 31, 32, 33 has a different particle size range.
  • the container lid or cap 2 has three sizes of delivery aperture 24, a first delivery aperture 36, a second delivery aperture 37 and a third delivery aperture 38.
  • Each delivery aperture 24, 36, 37, 38 is dimensioned to allow one or more amylase inhibitor to be delivered from the container 1.
  • the first delivery aperture 36 is the smallest and it will allow only one amylase inhibitor 31, 32, 33 through
  • the second delivery aperture 37 is large enough to allow a larger particle size through thus will allow an additional amylase inhibitor 31, 32, 33 to pass through
  • the third delivery aperture 38 allows any inhibitor 30, 31, 32, 33 present to pass through.
  • the container 1 is inverted and by manual action the inhibitor 30 is delivered from the container 1 to a target 40.
  • the target 40 is a piece of food or a drink prior to consumption, but, it may equally be delivered to food or drink during preparation, or cooking.
  • the inhibitor 30 is in the form of a liquid or semi liquid/gel container body 4 is a truncated cone with the body wall 8 being a flexible material.
  • the container lid or cap 2 includes a cap nozzle 50, where the cap nozzle 50 is a truncated cone with the largest cross section located closest to the lid wall 22, and the smallest cross section coterminous with the single delivery aperture 24.
  • This second aspect see Figure 5, may also include a protector 52 (shown in dashed lines and only in figure 5) which is a cap configured to engage with the cap nozzle 50 to protect or seal off the delivery aperture 24.
  • the protector 52 is attached to the container lid or cap 2 by a retaining strap 53, though it may also remain in place by friction.
  • the body wall 8, in this second aspect, is preferably made of a flexible material, so that the container body 4 can be squeezed to deform the body wall 8 and thus expel the inhibitor 30 from the delivery aperture 24.
  • the alternative is that the container is inverted (as shown in Figure 8) and the inhibitor 30 exits the container 1 under the force of gravity, or by shaking and gravity.
  • the inhibitor 30 is a liquid, semi-liquid or gel with one or more amylase inhibitors 31, 32, 33 present in the form of this liquid, semi-liquid or gel.
  • the amylase inhibitor 31, 32, 33 is dissolved, suspended or otherwise present within a liquid, semi-liquid or gel carrier.
  • the second aspect of the container 1 is shown delivering the inhibitor 30 via the cap nozzle 50 to a target 40.
  • the container body 4 is shown as transparent or translucent so that the level 60 of inhibitor 30 present can be determined. This is most likely to be done by marking the container body 4 at intervals (regular, irregular, specific volume, specific mass) so that the amount delivered can be controlled.
  • the container 1 includes a dose control mechanism 65 (shown in dashed lines as it is only preferred) that controls the amount of inhibitor delivered. For solid inhibitors this can be similar to the sugar containers that deliver 1 ⁇ 2 teaspoon of sugar each inversion, or like spirit delivery bottles used in bars where a specific volume of liquid is delivered each inversion.
  • the container 1 may be pressurised and contain gaseous fluids to allow the inhibitor 30 to be sprayed.
  • the inhibitor 30 can be particulate or fluid, or a combination of these.
  • the inhibitor 30 may include dyes 100, filler 101 or additional agents 102 (such as stabilisers, carrier, anti-oxidants, flavourings, materials to prevent particle size reduction during use, etc.).
  • additional agents 102 such as stabilisers, carrier, anti-oxidants, flavourings, materials to prevent particle size reduction during use, etc.
  • a dye 100 may be used to determine the amount of inhibitor delivered to the target 40.
  • the dye 100 may also be used to indicate that the inhibitor 30 has been applied to the target 40, to minimise the chances of double dosing or allergic reactions.
  • an additional agent 101 is present, this could be a carrier such as a liquid/semi-liquid/gel into which one or more amylase inhibitor 31, 32, 33 has been dissolved or suspended.
  • the container 1 is similar to a toothpaste tube with the inhibitor 30 in the form of a fluid paste.
  • the inhibitor 30 could have stripes with the specific colours of the stripes indicating the amylase inhibitor 31, 32, 33 present in that stripe, thus allow the identification of the amylase inhibitors 31, 32, 33 and relative ratios to ensure the correct inhibitor 30 is added.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Mechanical Engineering (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Closures For Containers (AREA)

Abstract

La présente invention concerne un récipient à l'intérieur duquel est stocké au moins un inhibiteur d'amylase, ce récipient ayant un couvercle ou un bouchon qui comprend une ou plusieurs ouvertures par lesquelles l'inhibiteur peut sortir du récipient. L'inhibiteur peut se présenter sous une forme divisée, par exemple sous la forme de cristaux ou d'une matière particulaire, sous une forme liquide ou semi-liquide.
PCT/AU2019/050781 2018-07-25 2019-07-25 Récipient pour administration d'inhibiteur d'amylase WO2020019033A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2018902684 2018-07-25
AU2018902684A AU2018902684A0 (en) 2018-07-25 Container for amylase inhibitor delivery

Publications (1)

Publication Number Publication Date
WO2020019033A1 true WO2020019033A1 (fr) 2020-01-30

Family

ID=69180215

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/AU2019/050781 WO2020019033A1 (fr) 2018-07-25 2019-07-25 Récipient pour administration d'inhibiteur d'amylase

Country Status (1)

Country Link
WO (1) WO2020019033A1 (fr)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998016438A1 (fr) * 1996-10-15 1998-04-23 The Procter & Gamble Company Receptacle portatif pour la predissolution d'une composition detergente
US20050031549A1 (en) * 2003-06-09 2005-02-10 Nastech Pharmaceutical Company Inc. Compositions and methods for enhanced mucosal delivery of growth hormone
US20080032909A1 (en) * 2006-05-05 2008-02-07 De Buzzaccarini Francesco Compact fluid laundry detergent composition
JP3150152U (ja) * 2009-02-17 2009-04-30 富美雄 藤田 ラインストーン等の粒状物用ケース
US20090152281A1 (en) * 2007-12-14 2009-06-18 Mark Richard Bowes Container with a device to prevent clogging of a dispensing device of the container
US7909212B2 (en) * 2006-05-03 2011-03-22 Gateway Plastics, Inc. Closure for a container

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998016438A1 (fr) * 1996-10-15 1998-04-23 The Procter & Gamble Company Receptacle portatif pour la predissolution d'une composition detergente
US20050031549A1 (en) * 2003-06-09 2005-02-10 Nastech Pharmaceutical Company Inc. Compositions and methods for enhanced mucosal delivery of growth hormone
US7909212B2 (en) * 2006-05-03 2011-03-22 Gateway Plastics, Inc. Closure for a container
US20080032909A1 (en) * 2006-05-05 2008-02-07 De Buzzaccarini Francesco Compact fluid laundry detergent composition
US20090152281A1 (en) * 2007-12-14 2009-06-18 Mark Richard Bowes Container with a device to prevent clogging of a dispensing device of the container
JP3150152U (ja) * 2009-02-17 2009-04-30 富美雄 藤田 ラインストーン等の粒状物用ケース

Similar Documents

Publication Publication Date Title
US5013321A (en) Gel-dispensing pacifier
US4569463A (en) Controlled dispensing apparatus
RU2313260C2 (ru) Соломинка для ароматизации напитка
RU2223902C2 (ru) Сосуд с двумя или более отделениями
US8485378B2 (en) Multi-container packages for dispensing liquid and dry food
US20100200437A1 (en) Dispensing Capsule
USRE33083E (en) Controlled dispensing apparatus
EP0806197B1 (fr) Dispositif de remplissage manuel de capsules
US9339439B2 (en) Pharmaceutical container system
US20120024812A1 (en) Water bottle with multiple drink dosage device
JPH11502450A (ja) 有益物質の経口投与
US8376134B1 (en) Drink bottle with multiple drink dosage device
US9045262B2 (en) Packages for dispensing liquid and dry food
US20050139622A1 (en) Dosing cap for powders or liquids
WO2016077352A1 (fr) Récipient pour le stockage et le transfert de substances en poudre
AU2012356241A1 (en) Dispensing closure
CN109693883B (zh) 一种定量药瓶
US3380632A (en) Collapsible container
US1869120A (en) Dispensing device
US5839619A (en) Measuring dispenser
WO2020019033A1 (fr) Récipient pour administration d'inhibiteur d'amylase
GB2400837A (en) Device for feeding infants
DE3668302D1 (de) Spender fuer fliessfaehige produkte wie fluessigkeiten, pastoese, pulverfoermige und koernige massen.
CN102791174A (zh) 分配组件
US5180080A (en) Dispenser and method of viewing granular dry matter as it is being dispensed

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 19839988

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 19839988

Country of ref document: EP

Kind code of ref document: A1